TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Healius Limited ( (AU:HLS) ) just unveiled an update.
Healius Limited has released its corporate governance statement for the financial year ending June 30, 2025. The statement, approved by the board, outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations. This disclosure is part of Healius’s commitment to transparency and accountability in its operations, potentially enhancing stakeholder trust and reinforcing its market position.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing medical and diagnostic services. The company focuses on delivering quality healthcare solutions and is listed on the Australian Securities Exchange (ASX).
Average Trading Volume: 4,967,969
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$548.2M
See more data about HLS stock on TipRanks’ Stock Analysis page.